190 related articles for article (PubMed ID: 10917998)
1. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system.
Sasajima T; Takano Y; Hiraishi Y; Goh K; Inaba M; Azuma N; Sasajima Y; Yamazaki K; Yamamoto H
J Vasc Surg; 2000 Aug; 32(2):374-82. PubMed ID: 10917998
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB
Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517
[TBL] [Abstract][Full Text] [Related]
3. An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.
Wootton DM; Popel AS; Alevriadou BR
Biotechnol Bioeng; 2002 Feb; 77(4):405-19. PubMed ID: 11787013
[TBL] [Abstract][Full Text] [Related]
4. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.
Houard X; Rouzet F; Touat Z; Philippe M; Dominguez M; Fontaine V; Sarda-Mantel L; Meulemans A; Le Guludec D; Meilhac O; Michel JB
J Pathol; 2007 May; 212(1):20-8. PubMed ID: 17352452
[TBL] [Abstract][Full Text] [Related]
5. [Plasminogen activation and regulation of fibrinolysis].
Madoiwa S
Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
[TBL] [Abstract][Full Text] [Related]
6. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
7. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
9. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
Savchuk AN
Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis-resistant carbonylated fibrin detected in thrombi attached to the vascular wall of abdominal aortic aneurysms.
Suzuki Y; Tanaka H; Horinouchi T; Sano H; Honkura N; Unno N; Miwa S; Urano T
Sci Rep; 2020 Nov; 10(1):20728. PubMed ID: 33244022
[TBL] [Abstract][Full Text] [Related]
12. [PC-12 cells hydrolyze the fibrin clot by producing both plasminogen and its tissue activator].
Petrova IuI; Savchuk OM; Kalashnyk OM; Platonova TM; Skok MV; Cederholm-Williams S
Ukr Biokhim Zh (1999); 2004; 76(2):64-8. PubMed ID: 15915713
[TBL] [Abstract][Full Text] [Related]
13. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
Weitz JI; Leslie B; Ginsberg J
J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
[TBL] [Abstract][Full Text] [Related]
14. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
15. Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins.
Gombás J; Tanka-Salamon A; Skopál J; Nagy Z; Machovich R; Kolev K
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):82-8. PubMed ID: 18180621
[TBL] [Abstract][Full Text] [Related]
16. Herpesviruses enhance fibrin clot lysis.
Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
[TBL] [Abstract][Full Text] [Related]
17. Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.
Whyte CS; Mostefai HA; Baeten KM; Lucking AJ; Newby DE; Booth NA; Mutch NJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672724
[TBL] [Abstract][Full Text] [Related]
18. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
19. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
[TBL] [Abstract][Full Text] [Related]
20. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]